fashion -WSS

fashion

author：Wikipedia 2025-09-27 13:02:24 - browse：2343

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Florida health officials providing scant details on measles cases

entertainment

Wikipedia

WSS

Cord blood banking comes at a high cost to babies

$1 billion proposal to grow Boston, Massachusetts biotech

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

At ASCO, AstraZeneca reports strong data for breast cancer drug

Readout Newsletter: BridgeBio, Akero, and human embryo models

Innovation in antibiotics is ailing. 'Brain drain' may kill it

entertainment

fashion

focus

Moonlake's readout produced a cash windfall. Risks remain

Ancient Greek ideas underpin modern concepts of pregnancy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Letters to First Opinion on caregivers, digital health, and more

The high cost of giving birth even with insurance

Longer MASH drug regimen improved liver, Akero study finds

Trump demands the U.S. pay no more for drugs than other countries … again

Pregnant women don't need prenatal multivitamins, study concludes

Psychedelics group wrestles with new pharma identity

Ancient Greek ideas underpin modern concepts of pregnancy

Wikipedia

He's 19 months old and has one of the world’s rarest diseases

Let's speed up science by embracing open access publishing

Ionis drug prevents swelling attacks due to hereditary angioedema

First over

Pregnant women don't need prenatal multivitamins, study concludes

NIH documents show early flaws of $1.6 billion long Covid program

focus

entertainment

Wikipedia

entertainment